EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 14 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $114,000 | 0.0% | 11,385 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | +1.8% | 11,385 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $112,000 | -0.9% | 11,385 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $113,000 | 0.0% | 11,385 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $113,000 | -2.6% | 11,385 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $116,000 | +0.9% | 11,385 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $115,000 | -5.0% | 11,385 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $121,000 | – | 11,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 248,674 | $2,578,749 | 1.28% |
| Verition Fund Management LLC | 397,603 | $4,115,191 | 0.06% |
| CLEAR STREET LLC | 2,740 | $28 | 0.00% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1 | $10 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |